Ellis Michael P, Bacorn Colin, Luu Kieu-Yen, Lee Sophie C, Tran Steven, Lillis Christopher, Lim Michele C, Yiu Glenn
Ophthalmic Surg Lasers Imaging Retina. 2020 May 1;51(5):S26-S34. doi: 10.3928/23258160-20200108-04.
To evaluate the financial sustainability of teleophthalmology screening for diabetic retinopathy (DR) using telehealth billing codes.
The authors performed an Institutional Review Board-approved retrospective review of medical records, billing data, and quality metrics at the University of California Davis Health System from patients screened for DR through an internal medicine-based telemedicine program using CPT codes 92227 or 92228.
A total of 290 patients received teleophthalmology screening over a 12-month period, resulting in an increase in the DR screening rate from 49% to 63% (P < .0001). The average payment per patient was $19.86, with an estimated cost of $41.02 per patient. The projected per-patient incentive bonus was $43.06 with a downstream referral revenue of $39.38 per patient. One hundred seventy-eight clinic visits were eliminated, providing an estimated cost savings of $42.53 per patient.
Sustainable teleophthalmology screening may be achieved by billing telehealth codes but only with health care incentive bonuses, patient referrals, and by accounting for the projected cost-savings of eliminating office visits. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:S26-S34.].
使用远程医疗计费代码评估糖尿病视网膜病变（DR）远程眼科筛查的财务可持续性。
作者对加利福尼亚大学戴维斯分校医疗系统中通过基于内科的远程医疗项目使用CPT代码92227或92228进行DR筛查的患者的病历、计费数据和质量指标进行了经机构审查委员会批准的回顾性研究。
在12个月期间，共有290例患者接受了远程眼科筛查，使DR筛查率从49%提高到63%（P <.0001）。每位患者的平均支付费用为19.86美元，估计每位患者的成本为41.02美元。预计每位患者的激励奖金为43.06美元，每位患者的下游转诊收入为39.38美元。减少了178次门诊就诊，估计每位患者节省成本42.53美元。
通过对远程医疗代码计费，或许可以实现可持续的远程眼科筛查，但前提是要有医疗保健激励奖金、患者转诊，并考虑到减少门诊就诊预计节省的成本。[《眼科手术、激光与视网膜成像》。2020；51：S26 - S34。]
